Status:

TERMINATED

Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy

Lead Sponsor:

Douglas Trask

Conditions:

Gastro-esophageal Reflux

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this research study is to measure acid reflux into the throat both before and after medical treatment in people who have had radiation therapy to their head and neck for the treatment o...

Detailed Description

The annual incidence of squamous cell carcinoma of the head and neck (SCCHN) is 40,000 cases per year in the US and 60,000 cases per year in Europe. Radiation therapy is employed in combination with c...

Eligibility Criteria

Inclusion

  • Signed informed consent
  • History of head and neck cancer
  • Radiation Therapy (external beam or IMRT)
  • Must have received equal or greater than 5000 cGy cumulative dose
  • Must have complaint of xerostomia
  • Greater than three month interval since radiation treatment

Exclusion

  • Subjects unable to tolerate pH-probe in past
  • Subjects currently on proton-pump inhibitor (PPI) or H-2 receptor antagonist therapy
  • Prior history of esophago-gastric surgery
  • Symptoms of gastrointestinal bleeding (melena, hematemesis)
  • Known hepatic cirrhosis or esophageal varices
  • Prior esophageal perforation
  • Pregnant, nursing or not likely to be using adequate contraceptive measures
  • Subjects not predicted to survive duration of study
  • Subjects with allergies or sensitivities to proton-pump inhibitors
  • Psychological, familial, sociological or geographical conditions which do not permit Study follow-up and compliance with study protocol
  • Subjects predicted to undergo surgery, chemotherapy or radiation therapy for head and neck cancer during the course of study

Key Trial Info

Start Date :

November 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2008

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00222079

Start Date

November 1 2004

End Date

February 1 2008

Last Update

December 14 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Iowa Department of Otolaryngology

Iowa City, Iowa, United States, 52242